s-nitroso-n-acetylcysteine has been researched along with Hypercholesterolemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Oliveira, MG; Estrela, HF; Franchini, KG; Krieger, MH; Laurindo, FR; Santos, KF; Santos, L; Shishido, SM; Spadari-Bratfisch, RC; Wanschel, AC | 1 |
de Souza, HP; dos Santos, L; Garcia, JA; Krieger, MH; Moura, AL; Ricardo, KF; Shishido, SM; Spadari-Bratfisch, RC; Wanschel, AC | 1 |
2 other study(ies) available for s-nitroso-n-acetylcysteine and Hypercholesterolemia
Article | Year |
---|---|
Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice.
Topics: Acetylcysteine; Animals; Atherosclerosis; Blotting, Western; Hypercholesterolemia; Immunohistochemistry; Mice; Mice, Knockout; Nitric Oxide Donors; Nitric Oxide Synthase; Receptors, LDL | 2006 |
S-nitroso-N-acetylcysteine (SNAC) prevents myocardial alterations in hypercholesterolemic LDL receptor knockout mice by antiinflammatory action.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Blood Pressure; CD40 Ligand; Gene Expression Regulation, Enzymologic; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Nitric Oxide Synthase Type III; Receptors, LDL | 2008 |